Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
about
Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinomaCorosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro.SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant articleUrotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma.Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.Preoperative prediction of microvascular invasion of hepatocellular carcinoma using (18)F-FDG PET/CT: a multicenter retrospective cohort study.Women receive more inpatient resections and ablations for hepatocellular carcinoma than men.Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents
P2860
Q36905913-8A780C88-EBA5-421F-999A-3DDFCB2D90DFQ38799448-DE9F5E27-DC68-492D-BA9D-C179D62A056EQ38809698-A02D6803-57FE-419E-AEC3-B47828DBDF63Q40373005-5140836D-4BD1-4112-89FF-DEF9B191CF1AQ41090821-9FECDEE2-25B4-404F-B4CA-02607D4B0984Q41613067-772F1845-F390-4912-B71C-4C4B65E1F1EFQ41614975-B49C2002-FC57-414E-B738-A2DBCC0146F4Q42679004-9F178DB6-0C27-46DD-976C-2D537531C29EQ47208418-202A8487-48CE-46E5-8D4B-2EA1BBBEFCBAQ48513998-1BE52D79-BF5C-4D96-91E7-86AA0A5471B9Q55077255-D2FA3A29-59A9-4583-9287-715D1C7F696EQ58746251-6073CBF7-7E36-463E-B426-A54DA133ED5C
P2860
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@ast
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@en
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@nl
type
label
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@ast
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@en
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@nl
prefLabel
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@ast
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@en
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@nl
P2860
P356
P1476
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
@en
P2093
Liat Mlynarsky
P2860
P304
P356
10.4254/WJH.V7.I3.566
P407
P577
2015-03-27T00:00:00Z